Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses

European Journal of Biochemistry

Volumn 268, Issue 1, 2001, Pages 160-167

  Jostock, Thomas ^a   Müllberg, Jürgen ^a   Özbek, Suat ^a   Atreya, Raja ^a   Blinn, Guido ^a   Voltz, Nicole ^a   Fischer, Martina ^a   Neurath, Markus F ^a   Rose John, Stefan ^a,b  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

Author keywords

Cytokine receptors; Cytokines; Soluble receptors

Indexed keywords

GLYCOPROTEIN GP 130; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; LEUKEMIA INHIBITORY FACTOR; ONCOSTATIN M; RECOMBINANT PROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; COMPLEX FORMATION; CROHN DISEASE; DIMERIZATION; LAMINA PROPRIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DENSITY; SIGNAL TRANSDUCTION;

ACUTE-PHASE REACTION; ANIMALS; ANTIGENS, CD; APOPTOSIS; CELL DIVISION; CELLS, CULTURED; CROHN DISEASE; CYTOKINE RECEPTOR GP130; HUMANS; LEUKOCYTES, MONONUCLEAR; MEMBRANE GLYCOPROTEINS; MICE; PROTEIN SYNTHESIS INHIBITORS; RECEPTORS, INTERLEUKIN-6; RECOMBINANT PROTEINS; SIGNAL TRANSDUCTION; SOLUBILITY; TRANSFECTION; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0035160256     PISSN: 00142956     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1432-1327.2001.01867.x     Document Type: Article

References (48)

1. gp130 and the interleukin-6 family of cytokines
2. IL-6 dependent biology and therapy: Where do we stand and what are the options?
3. Soluble receptors for cytokines and growth factors: Generation and biological function
4. Interleukin-6 and soluble interleukin-6 receptor: Direct stimulation of gp130 and hematopoiesis
5. Neuronal activities of IL-6 type cytokines often depend on soluble cytokine receptors
6. The function of the soluble interleukin 6 (IL-6) receptor in vivo: Sensitization of human soluble IL-6 receptor transgenic mice towards IL-6 and prolongation of the plasma half-life of IL-6
7. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment
8. Sympathetic neurons can produce and respond to interleukin-6
9. Soluble interleukin-6 receptor triggers osteoclast formation by interleukin 6
10. Novel path of activation of primary human smooth muscle cells: Upregulation of gp130 creates an autocrine activation loop by IL-6 and its soluble receptor
11. gp130 and c-Kit signalings synergize for ex vivo expansion of human primitive hemopoietic progenitor cells
12. Soluble forms of the interleukin-6 signal-transducing receptor component gp130 in human serum possessing a potential to inhibit signals through membrane-anchored gp130
13. Cloning and expression of an alternatively spliced mRNA encoding a soluble form of the human interleukin-6 signal transducer gp130
14. Characterization of soluble gp130 released by melanoma cell lines: A polyvalent antagonist of cytokines from the interleukin 6 family
15. A designer cytokine with high activity on human hematopoietic progenitor cells
16. The membrane proximal cytokine receptor domain of the human interleukin-6-receptor is sufficient for ligand binding but not for gp130 association
17. Immunoadhesins of IL-6 and Hyper-IL-6
18. Complex of soluble human IL-6-receptor/IL-6 up-regulates expression of acute-phase proteins
19. Soluble interleukin 6 receptor is biologically active in vivo
20. Soluble forms of CD40 inhibit biologic responses of human B cells
21. The R27080 glycoprotein is abundantly secreted from human cytomegalovirus-infected fibroblasts
22. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
23. Receptor recognition sites of cytokines are organized as exchangeable moduls: Transfer of the LIFR binding site from CNTF to IL-6
24. Blockade of IL-6 transsignaling abrogates established experimental colitis in mice by suppression of the antiapoptotic resistance of lamina propria T cells
25. Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130
26. The membrane distal half of gp130 is responsible for the formation of a ternary complex with IL-6 and the IL-6 receptor
27. Interleukin-6: An overview
28. Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells
29. Lamina propria T cells in Crohn's disease and other gastrointestinal inflammation show defective CD2 pathway-induced apoptosis
30. Resistance of Crohn's disease T cells to multiple apoptotic signals is associated with a Bcl-2/Bax mucosal imbalance
31. The soluble interleukin-6 (IL-6) receptor/IL-6 fusion protein enhances in vitro maintenance and proliferation of human CD34 (+) CD38 (-/low) cells capable of repopulating severe combined immunodeficiency mice
32. Soluble human interleukin-6 receptor. Expression in insect cells, purification and characterization
33. Engineering human interleukin-6 to obtain variants with strongly enhanced bioactivity
34. Recombinant human scFv antibodies recognizing human interleukin-6: Specific targeting of cytokine secreting cells
35. Cloning and expression of the human interleukin-6 (BSF-2/IFN beta 2) receptor
36. Soluble IL-6 receptor potentiates the antagonistic activity of soluble gp130 on IL-6 responses
37. Identification and characterization of two distinct truncated forms of gp130 and a soluble form of leukemia inhibitory factor receptor alphachain in normal human urine and plasma
38. LIF and OM directly interact with a soluble form of gp130, the IL-6 receptor signal transducing subunit
39. Complex of the soluble IL-11 receptor and IL-11 acts as IL-6-type cytokine in hepatic and nonhepatic cells
40. Serum levels of interleukin 6 (IL-6), oncostatin M, soluble IL-6 receptor, and soluble gp130 in patients with systemic sclerosis
41. CSF and serum levels of soluble interleukin-6 receptors (sIL-6R and sgp130), but not of interleukin-6 are altered in multiple sclerosis
42. Interleukin-6 in biology and medicine
43. Human soluble IL-6 receptor: Its detection and enhanced release by HIV infection
44. A possible role for soluble IL-6 receptor in the pathogenesis of systemic onset juvenile chronic arthritis
45. Enhanced production of interleukin-6 (IL-6), oncostatin M and soluble IL-6 receptor by cultured peripheral blood mononuclear cells from patients with systemic sclerosis
46. Soluble IL-6 Receptor leads to a paracrine modulation of the hepatic acute phase response in double transgenic mice
47. Increased interleukin-6 levels, interleukin-6 receptor and gp130 expression in peripheral lymphocytes of patients with inflammatory bowel disease
48. Interleukin-6 and soluble interleukin-6 receptor in the colonic mucosa of inflammatory bowel disease